ASCO's Government Relations Committee establishes advocacy priorities on an annual basis. These priorities are updated as needed to reflect emerging issues. Ensure Access to Affordable Health Care for ...

Background: About 30.3-58.0% of patients who undergo esophagectomy may experience recurrence. The efficacy of postoperative chemoradiation has not been demonstrated in a randomized trial in patients ...

ASCO’s growing roster of highly respected, award-winning reports play an important role in informing the public, media, and government officials about the state of cancer care in America, advances in ...

Background: Drugs targeting pathogen associated molecular patterns are an attractive strategy to stimulate the immune system. Toll-like receptors (TLR) have generated significant interest as an ...

Ensuring high-quality care for every cancer patient is a key component of ASCO’s mission. In keeping with this goal, ASCO offers oncology providers the resources to help deliver high-quality cancer ...

As Conquer Cancer grantees, you and your institution are responsible for adhering to the terms and conditions of your award. The content below provides key information for you or your grants ...

Our grants and awards support basic, translational and clinical cancer research done by gifted physician-scientists at every stage of their careers, from the best and brightest among young ...

*Rate per 100,000 person-months.

ASCO provides a variety of resources to educate its members, their staff, and other health care professionals on appropriate and up-to-date information on billing and coding for oncology-related ...

Matched cisplatin-ineligible muscle-invasive bladder cancer patients undergoing IRC vs. NAP.

Response rate of breast cancer patients to surveys with different mannersof distribution.

User data for experts in oncology specialties.